# Advanced Imaging for Pulmonary Fibrosis

> **NCT06532071** · PHASE2 · RECRUITING · sponsor: **Peter Caravan** · enrollment: 60 (estimated)

## Conditions studied

- Pulmonary Fibrosis

## Interventions

- **DRUG:** [68Ga]CBP8
- **DRUG:** Gadoterate Meglumine

## Key facts

- **NCT ID:** NCT06532071
- **Lead sponsor:** Peter Caravan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-21
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06532071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06532071, "Advanced Imaging for Pulmonary Fibrosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06532071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*